O

Organon & Co
D

OGN

9.88000
USD
0.03
(0.30%)
مغلق
حجم التداول
65,420
الربح لكل سهم
7
العائد الربحي
8.7
P/E
3
حجم السوق
2,568,365,902
أصول ذات صلة
SUSHIUSD
SUSHIUSD
-0.00227
(-0.37%)
0.61220 USD
AAVEUSD
AAVEUSD
-1.298
(-0.51%)
253.504 USD
C
COMP
-0.05500
(-0.92%)
5.91000 USD
L
LINK
0.16000
(2.91%)
5.66000 USD
المزيد
الأخبار المقالات

العنوان: Organon & Co

القطاع: Healthcare
الصناعة: Drug Manufacturers - General
Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.